Loading
Acura Pharmaceuticals, Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by SKELLY WILLIAM G, was filed 18 Dec 2017.
Insider Decl.
89
Thresholds
n/a
Buy Volume
€187,015
12 ops. · all time
Sell Volume
€185,515
1 ops. · all time
Since the insiders bought
- -68.2%Entry US$0.44 · Close at T+365 US$0.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
as of FY 2021FY ended December 2021 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$1.6M
EBITDA-US$589k-38% margin
Net income-US$879k-56.2% margin
Valuation
P/Book0.0x
Beta52.27
Balance sheet & cash
Total debtUS$200k
Free Cash Flow-US$742k
Debt / Equity84%
Profitability & ownership
ROA-58.5%
% insiders1.7%
% institutions0.0%
Last declaration on 15 January 2026
Declarations89 total
50,000 sharesCommon StockSEC:0001104659-26-004048:0
50,000 sharesCommon StockSEC:0001104659-26-004053:0
50,000 sharesCommon StockSEC:0001104659-26-004050:0
50,000 sharesCommon StockSEC:0001104659-25-008916:0
50,000 sharesCommon StockSEC:0001104659-25-006020:0
50,000 sharesCommon StockSEC:0001104659-25-006021:0
50,000 sharesCommon StockSEC:0001104659-24-000284:0
50,000 sharesCommon StockSEC:0001104659-24-000290:0
37,500 sharesCommon StockSEC:0001104659-24-000283:0
50,000 sharesCommon StockSEC:0001104659-24-000288:0
40,000 sharesCommon StockSEC:0001104659-23-119812:0
40,000 sharesCommon StockSEC:0001104659-23-119814:0
40,000 sharesCommon StockSEC:0001104659-23-119813:0
40,000 sharesCommon StockSEC:0001104659-23-119811:0
34,000 sharesCommon StockSEC:0001104659-23-001410:0
40,000 sharesCommon StockSEC:0001104659-23-001411:0
66,666 sharesCommon StockSEC:0001104659-23-001403:0
66,666 sharesCommon StockSEC:0001104659-23-001404:0
50,000 sharesCommon StockSEC:0001104659-23-001412:0
20,000 sharesCommon StockSEC:0001104659-23-001413:0
66,666 sharesCommon StockSEC:0001104659-23-001406:0
66,666 sharesCommon StockSEC:0001104659-23-001399:0
63,666 sharesCommon StockSEC:0001104659-22-086713:0
43,333 sharesCommon StockSEC:0001104659-22-086715:0
24,666 sharesCommon StockSEC:0001104659-22-086711:0
25 of 89 declarations
About Acura Pharmaceuticals, Inc
On December 14, 2017, 8 filers at Acura Pharmaceuticals, Inc bought on the same day, the largest run of purchases in the record. Of the 92 filings published between January 5, 2016 and January 15, 2026, 12 are purchases, one is a sale, and 68 are option exercises, with 9 grants and 2 filings of another kind on top. Purchases make up 92% of market trades.
The record is spread out: 18 filings in 2017 and 20 in 2021, against 4 in 2016, 4 in 2019 and 3 in 2025. George K. Ross, a director, is the most frequent with 13 filings, ahead of William G. Skelly (12), Immanuel Thangaraj (11) and Robert A. Seiser, Treasurer & Controller (11), then Bruce F. Wesson (10). Each of the first three named, except Immanuel Thangaraj, has a single purchase.
Read moreShow less
This US health care company is listed on Nasdaq, and insiders hold 1.7% of it. Filings come out a median of 2 days after the trade, and 3 fall within the last twelve months, none a purchase.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
